Larger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success.
Melanie Senior
Advertisement
Melanie Senior, author, Evaluate’s Orphan Drug Report 2022
Articles by Melanie Senior
Advertisement
Latest Updated Articles
Orphan Drugs: From Niche to MainstreamPublished: June 15th 2022 | Updated: July 13th 2022
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Launches Employer Connect Platform Offering Obesity Coverage Options
2
The Ongoing Impact of MFN Pricing
3
Three Imperatives Pharma Leaders Should Prioritize This Year
4
Pharma Funding Roundup: Cognito Therapeutics Closes Oversubscribed $105 Million Series C Financing, Nexcure Launches $19 Million Series A Financing
5